Dagmar Silbert

3.2k total citations
42 papers, 2.6k citations indexed

About

Dagmar Silbert is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Dagmar Silbert has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Dagmar Silbert's work include Drug Transport and Resistance Mechanisms (30 papers), Liver Disease Diagnosis and Treatment (19 papers) and Pediatric Hepatobiliary Diseases and Treatments (15 papers). Dagmar Silbert is often cited by papers focused on Drug Transport and Resistance Mechanisms (30 papers), Liver Disease Diagnosis and Treatment (19 papers) and Pediatric Hepatobiliary Diseases and Treatments (15 papers). Dagmar Silbert collaborates with scholars based in Austria, United States and Sweden. Dagmar Silbert's co-authors include Peter Fickert, Michael Trauner, Gernot Zollner, Andrea Fuchsbichler, Helmut Denk, J. Gumhold, Martin Wagner, Hanns–Ulrich Marschall, Kurt Zatloukal and Tarek Moustafa and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Dagmar Silbert

41 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dagmar Silbert Austria	21	1.8k	1.2k	1.1k	919	469	42	2.6k
Carsten Gartung Germany	27	1.3k 0.7×	833 0.7×	628 0.6×	506 0.6×	326 0.7×	55	2.3k
Ekkehard Sturm Germany	25	2.0k 1.1×	2.0k 1.7×	884 0.8×	753 0.8×	253 0.5×	86	3.1k
Emina Halilbasic Austria	32	1.6k 0.9×	1.3k 1.1×	1.7k 1.6×	1.4k 1.6×	452 1.0×	77	3.5k
J. Gumhold Austria	17	1.0k 0.6×	749 0.6×	737 0.7×	641 0.7×	281 0.6×	29	1.7k
J. Marleen L. de Vree Netherlands	9	1.4k 0.8×	965 0.8×	411 0.4×	366 0.4×	141 0.3×	11	1.9k
M Ananthanarayanan United States	16	1.5k 0.8×	1.1k 0.9×	477 0.4×	254 0.3×	276 0.6×	26	2.1k
Diana Jung Switzerland	15	1.2k 0.7×	762 0.7×	427 0.4×	207 0.2×	286 0.6×	23	1.6k
Danièle Cresteil France	11	1.1k 0.6×	958 0.8×	548 0.5×	481 0.5×	108 0.2×	18	1.6k
R. Raedsch Germany	25	718 0.4×	771 0.7×	691 0.6×	711 0.8×	170 0.4×	77	1.9k
R. Ottenhoff Netherlands	10	1.4k 0.8×	953 0.8×	481 0.5×	318 0.3×	118 0.3×	12	1.9k

Countries citing papers authored by Dagmar Silbert

Since Specialization

Citations

This map shows the geographic impact of Dagmar Silbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Silbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Silbert more than expected).

Fields of papers citing papers by Dagmar Silbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Silbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Silbert. The network helps show where Dagmar Silbert may publish in the future.

Co-authorship network of co-authors of Dagmar Silbert

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Silbert. A scholar is included among the top collaborators of Dagmar Silbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Silbert. Dagmar Silbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuchs, Claudia, Thierry Claudel, Guenter Haemmerle, et al.. (2012). Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology. 56(1). 270–280. 75 indexed citations

Lax, Sigurd, et al.. (2011). Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis. International Journal of Cancer. 130(10). 2232–2239. 90 indexed citations

Moustafa, Tarek, Peter Fickert, Christoph Magnes, et al.. (2011). Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury. Gastroenterology. 142(1). 140–151.e12. 126 indexed citations

Baghdasaryan, Anna, Thierry Claudel, J. Gumhold, et al.. (2011). Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− ( Abcb4 −/−) mouse cholangiopathy model by promoting biliary HCO Symbol output. Hepatology. 54(4). 1303–1312. 179 indexed citations

Baghdasaryan, Anna, Thierry Claudel, Astrid Kosters, et al.. (2010). Curcumin improves sclerosing cholangitis in Mdr2 ^−/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut. 59(4). 521–530. 78 indexed citations

Fickert, Peter, Andrea Thueringer, Tarek Moustafa, et al.. (2010). The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Laboratory Investigation. 90(6). 844–852. 39 indexed citations

Halilbasic, Emina, Romina Fiorotto, Peter Fickert, et al.. (2009). Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2 −/− mice†‡§. Hepatology. 49(6). 1972–1981. 119 indexed citations

Jahnel, Jörg, Peter Fickert, Cord Langner, et al.. (2009). Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver International. 29(9). 1316–1325. 26 indexed citations

Loebermann, Micha, Martina Sombetzki, Cord Langner, et al.. (2009). Imbalance of pro‐ and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection–induced liver fibrosis. Tropical Medicine & International Health. 14(11). 1418–1425. 14 indexed citations

10.

Sombetzki, Martina, Peter Fickert, Micha Loebermann, et al.. (2008). 50 24-NOR-URSODEOXYCHOLIC ACID AS NOVEL THERAPEUTIC STRATEGY FOR INFLAMMATION-INDUCED LIVER FIBROSIS IN A MURINE MODEL OF SCHISTOSOMA MANSONI INFECTION. Journal of Hepatology. 48. S21–S22. 1 indexed citations

11.

Wagner, Martin, Gernot Zollner, Peter Fickert, et al.. (2007). Hepatobiliary Transporter Expression in Intercellular Adhesion Molecule 1 Knockout and Fas Receptor-Deficient Mice after Common Bile Duct Ligation Is Independent of the Degree of Inflammation and Oxidative Stress. Drug Metabolism and Disposition. 35(9). 1694–1699. 11 indexed citations

12.

Zollner, Gernot, Martin Wagner, Peter Fickert, et al.. (2007). Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver International. 27(7). 920–929. 101 indexed citations

13.

Marschall, Hanns–Ulrich, Martin Wagner, Karl Bodin, et al.. (2005). Fxr−/− mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. Journal of Lipid Research. 47(3). 582–592. 97 indexed citations

14.

Marschall, Hanns–Ulrich, Martin Wagner, Gernot Zollner, et al.. (2005). Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in Humans. Gastroenterology. 129(2). 476–485. 237 indexed citations

15.

Zollner, Gernot, Martin Wagner, Peter Fickert, et al.. (2005). Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(5). G798–G805. 65 indexed citations

16.

Zollner, Gernot, Martin Wagner, Tarek Moustafa, et al.. (2005). Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(5). G923–G932. 146 indexed citations

17.

Zollner, Gernot, Martin Wagner, Peter Fickert, et al.. (2005). Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver International. 25(2). 367–379. 113 indexed citations

18.

Wagner, Martin, Gernot Zollner, Peter Fickert, et al.. (2004). 303 Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients. Journal of Hepatology. 40. 93–93. 1 indexed citations

19.

Zollner, Gernot, Peter Fickert, Dagmar Silbert, et al.. (2003). Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. Journal of Hepatology. 38(6). 717–727. 211 indexed citations

20.

Wagner, Martin, Peter Fickert, Gernot Zollner, et al.. (2003). Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology. 125(3). 825–838. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact